IV Iron Therapy for Heart Failure and Iron Deficiency
(INFUSE-HFpEF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This randomized, double-blind, placebo-controlled clinical trial evaluates intravenous ferric derisomaltose in older adults with HFpEF and iron deficiency.
Who Is on the Research Team?
Marat Fudim
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for older adults who have heart failure with preserved ejection fraction (HFpEF) and are also low in iron. People with other major health issues or conditions that could interfere with the study may not be able to join.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Ferric derisomaltose
Trial Overview
The study is testing whether giving intravenous ferric derisomaltose (a type of iron given through a vein) helps people with HFpEF and iron deficiency, compared to a placebo (salt water). Participants are randomly assigned to one group or the other, and neither they nor their doctors know which treatment they're getting.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Aging (NIA)
Collaborator
Kaiser Permanente
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.